Novel oxazolo[4,5-g]quinazolin-2(1H)-ones: Dual inhibitors of EGFR and Src protein tyrosine kinasesJINSHENG LIN; WEI SHEN; JINGWEI XUE et al.European journal of medicinal chemistry. 2012, Vol 55, pp 39-48, issn 0223-5234, 10 p.Article

DUSP6 regulates drug sensitivity by modulating DNA damage responseBAGNYUKOVA, T. V; RESTIFO, D; BEEHARRY, N et al.British journal of cancer. 2013, Vol 109, Num 4, pp 1063-1071, issn 0007-0920, 9 p.Article

Enzastaurin inhibits tumours sensitive and resistant to anti-EGFR drugsGELARDI, T; CAPUTO, R; DAMIANO, V et al.British journal of cancer. 2008, Vol 99, Num 3, pp 473-480, issn 0007-0920, 8 p.Article

Non-mucinous and mucinous subtypes of adenocarcinoma with bronchioloalveolar carcinoma features differ by biomarker expression and in the response to gefitinibWISLEZ, Marie; ANTOINE, Martine; BAUDRIN, Laurence et al.Lung cancer. 2010, Vol 68, Num 2, pp 185-191, issn 0169-5002, 7 p.Article

Synthesis and evaluation of 2,7-diamino-thiazolo[4,5-d] pyrimidine analogues as anti-tumor epidermal growth factor receptor (EGFR) tyrosine kinase inhibitorsRONGHUI LIN; JOHNSON, Sigmond G; FUENTES-PESQUERA, Angel R et al.Bioorganic & medicinal chemistry letters (Print). 2009, Vol 19, Num 8, pp 2333-2337, issn 0960-894X, 5 p.Article

EGFR Inhibitors Enhanced the Susceptibility to NK Cell-mediated Lysis of Lung Cancer CellsKIM, Hyunsu; KIM, Sun-Hee; KIM, Mi-Ju et al.Journal of immunotherapy (1997). 2011, Vol 34, Num 4, pp 372-381, issn 1524-9557, 10 p.Article

Squamous cell carcinoma of the breastAPARICIO, I; MARTINEZ, A; HERNANDEZ, G et al.European journal of obstetrics, gynecology, and reproductive biology. 2008, Vol 137, Num 2, pp 222-226, issn 0301-2115, 5 p.Article

A novel diffusion cell model for the in vitro assessment of transcutaneous breast cancer therapeutics: Effect of permeants on MCF-7 cells cultured within the receptor compartmentDAVISON, Zoë; NICHOLSON, Robert I; DENYER, Stephen P et al.European journal of pharmaceutics and biopharmaceutics. 2010, Vol 75, Num 3, pp 411-417, issn 0939-6411, 7 p.Article

Ras Mutational Status Is a Biomarker for Resistance to EGFR Inhibitors in Colorectal CarcinomaDEMPKE, Wolfram C. M; HEINEMANN, Volker.Anticancer research. 2010, Vol 30, Num 11, pp 4673-4677, issn 0250-7005, 5 p.Article

Novel targets in gastric and esophageal cancerVALVERDE, Claudia Maria; MACARULLA, Teresa; CASADO, Esther et al.Critical reviews in oncology/hematology. 2006, Vol 59, Num 2, pp 128-138, issn 1040-8428, 11 p.Article

Ongoing and future trials of biologic therapies in lung cancerBUNN, Paul A; SHEPHERD, Frances A; SANDLER, Alan et al.Lung cancer. 2003, Vol 41, pp S175-S186, issn 0169-5002, SUP1Conference Paper

Interdisciplinary management of EGFR-inhibitor- induced skin reactions: a German expert opinionPOTTHOFF, K; HOFHEINZ, R; TRARBACH, T et al.Annals of oncology. 2011, Vol 22, Num 3, pp 524-535, issn 0923-7534, 12 p.Article

KRAS and BRAF: drug targets and predictive biomarkersVAKIANI, Efsevia; SOLIT, David B.Journal of pathology (Print). 2011, Vol 223, Num 2, pp 219-229, issn 0022-3417, 11 p.Article

MUC-1 (CA 15-3 antigen) as a highly reliable predictor of response to EGFR inhibitors in patients with bronchioloalveolar carcinoma : an experience on 26 patientsBEARZ, A; TALAMINI, R; VACCHER, E et al.The International journal of biological markers. 2007, Vol 22, Num 4, pp 307-311, issn 0393-6155, 5 p.Article

NSCLC cells adapted to EGFR inhibition accumulate EGFR interacting proteins and down-regulate microRNA related to epithelial-mesenchymal transition : OMICs technologies and development drugsMADER, Robert M; FOERSTER, Sarah; FRÖTSCHL, Roland et al.International journal of clinical pharmacology and therapeutics. 2014, Vol 52, Num 1, pp 92-94, issn 0946-1965, 3 p.Conference Paper

Spontaneous reporting of serious cutaneous reactions with protein kinase inhibitorsFAYE, Emmanuelle; BONDON-GUITTON, Emmanuelle; OLIVIER-ABBAL, Pascale et al.European journal of clinical pharmacology. 2013, Vol 69, Num 10, pp 1819-1826, issn 0031-6970, 8 p.Article

Synthesis and Anti-proliferative Activity of Substituted-Anilinoquinazolines and Its Relation to EGFR InhibitionEL ELLA, D. A. A; SALES, K. A; HASSAN, M et al.Arzneimittel-Forschung. 2012, Vol 62, Num 8, pp 360-366, issn 0004-4172, 7 p.Article

Predictive markers in the adjuvant therapy of non-small cell lung cancerFILIPITS, Martin; PIRKER, Robert.Lung cancer. 2011, Vol 74, Num 3, pp 355-363, issn 0169-5002, 9 p.Article

Quantifying the sensitivities of EGF receptor (EGFR) tyrosine kinase inhibitors in drug resistant non-small cell lung cancer (NSCLC) cells using hydrogel-based peptide arrayGHOSH, Gargi; XIAOLIANG YAN; LEE, Andrew G et al.Biosensors & bioelectronics. 2010, Vol 26, Num 2, pp 424-431, issn 0956-5663, 8 p.Article

Clinical significance and treatment of skin rash from erlotinib in non-small cell lung cancer patients : Results of an Experts Panel MeetingGRIDELLI, C; MAIONE, P; GROSSI, F et al.Critical reviews in oncology/hematology. 2008, Vol 66, Num 2, pp 155-162, issn 1040-8428, 8 p.Article

Molecular targeting therapy for pancreatic cancerXIONG, Henry Q.Cancer chemotherapy and pharmacology. 2004, Vol 54, pp S69-S77, issn 0344-5704, SUP1Conference Paper

Prise en charge des toxicités cutanées des thérapies dirigées contre les récepteurs du facteur de croissance épidermique : revue de la littérature = Management of cutaneous toxicities induced by epidermal growth factor receptor inhibitors : a reviewMESTDAGH, K; FINK, W; HENDLISZ, A et al.Revue médicale de Bruxelles. 2008, Vol 29, Num 6, pp 552-558, issn 0035-3639, 7 p.Article

New drug development in digestive neuroendocrine tumorsDURAN, I; SALAZAR, R; CASANOVAS, O et al.Annals of oncology. 2007, Vol 18, Num 8, pp 1307-1313, issn 0923-7534, 7 p.Article

Novel targeted therapies in the treatment of gastric and esophageal cancerTABEMERO, J; MACARULLA, T; RAMOS, F. J et al.Annals of oncology. 2005, Vol 16, Num 11, pp 1740-1748, issn 0923-7534, 9 p.Article

Tissue sampling in lung cancer: A review in light of the MERIT experienceRECK, Martin; HERMES, Andreas; TAN, Eng-Huat et al.Lung cancer. 2011, Vol 74, Num 1, pp 1-6, issn 0169-5002, 6 p.Article